Gastric cancer (HER2-positive metastatic) - trastuzumab: response to consultee, commentator and public comments on the ACD and comments from website consultation
|
Gastric cancer (HER2-positive metastatic) - trastuzumab: response to consultee, commentator and public comments on the ACD and comments from website consultation
29 September 2010 (263.11 Kb 16 sec) |
This page was last updated: 23 September 2010